王晓艺，中国科学院过程工程研究所项目研究员，博士生导师。于2011年在济宁医学院获学士学位，2014年在中国药科大学获硕士学位，2019年在复旦大学获得药剂学博士学位。2019-2021年在美国康涅狄格大学药学院从事博士后研究，2021-2023年在美国康涅狄格大学药学院担任Assistant Research Professor。2024年通过所引才计划入职中国科学院过程工程研究所，生物药制备与递送重点实验室，生物医药研究部。

目前主要致力于药物递送系统的研究，包括纳米制剂、长效高端注射剂如注射用混悬液和注射式原位成型植入剂等。迄今在药物递送领域重要期刊Advanced Drug Delivery Reviews、Journal of Controlled Release等发表论文25篇，其中第一（共一）作者论文14篇。申请专利5项，其中2项与美国公司达成专利许可协议。

1.Xiaoyi Wang, Ruifeng Wang, Mckenzie Roy, Owen Kwok, Yan Wang, Bin Qin, Diane J. Burgess. Long-acting injectable in situ forming implants: Impact of polymer attributes and API [J]. International Journal of Pharmaceutics (IF: 5.8), 2025, 670: 125080.

2.Xiaoyi Wang, Mckenzie Roy, Ruifeng Wang, Owen Kwok, Yinhang Wang, Yan Wang, Bin Qin, Diane J. Burgess. Towards In Vitro – In Vivo Correlation Models for In Situ Forming Drug Implants [J]. Journal of Controlled Release (IF: 10.8), 2024, 372: 648-660.

3.Xiaoyi Wang, Quanying Bao, Ruifeng Wang, Owen Kwok, Kellen Maurus, Yan Wang, Bin Qin, Diane J. Burgess. In Situ Forming Risperidone Implants: Effect of PLGA Attributes on Product Performance [J]. Journal of Controlled Release (IF: 10.8), 2023, 361:777-791.

4.Xiaoyi Wang, Quanying Bao, Ruifeng Wang, Tingting Li, Yan Wang, Bin Qin, Qi Li, Diane J. Burgess. In Vivo Characterization of Perseris and Compositionally Equivalent Formulations Using Rabbit Model [J]. International Journal of Pharmaceutics (IF: 5.8), 2023, 642: 123170.

5.Xiaoyi Wang, Quanying Bao, Ruifeng Wang, Bo Wan, Yan Wang, Bin Qin, Diane J. Burgess. Reverse Engineering of Perseris and Development of Compositionally Equivalent Formulations [J]. International Journal of Pharmaceutics (IF: 5.8), 2023, 639: 122948.

6.Quanying Bao, Xiaoyi Wang, Bo Wan, Yuan Zou, Yan Wang, Diane J Burgess. Development of In Vitro-In Vivo Correlations for Long-Acting Injectable Suspensions [J]. International Journal of Pharmaceutics (IF: 5.8), 2023, 634: 122642.   

7.Xiaoyi Wang, Quanying Bao, Min Sung Suh, Michail Kastellorizios, Ruifeng Wang, Diane J Burgess. Novel Adapter Method for In Vitro Release Testing of In Situ Forming Implants [J]. International Journal of Pharmaceutics (IF: 5.8), 2022, 621:121777. 

8.Xiaoyi Wang, Diane J. Burgess. Drug Release from In Situ Forming Implants and Advances in Release Testing [J]. Advanced Drug Delivery Reviews (IF: 16.1), 2021, 178: 113912.  

9.Xiaoyi Wang, Nana Meng, Songli Wang, Linwei Lu, Huan Wang, Changyou Zhan, Diane J. Burgess, Weiyue Lu. Factors Influencing the Immunogenicity and Immunotoxicity of Cyclic RGD Peptide-Modified Nanodrug Delivery Systems [J]. Molecular Pharmaceutics (IF: 4.939), 2020, 17: 3281-3290. 

10.Xiaoyi Wang, Nana Meng, Songli Wang, Yanyu Zhang, Linwei Lu, Ruifeng Wang, Huitong Ruan, Kuan Jiang, Huan Wang, Danni Ran, Changyou Zhan, Ker Yu, Diane J Burgess, Weiyue Lu. Non-Immunogenic, Low-Toxicity and Effective Glioma Targeting MTI-31 Liposomes [J]. Journal of Controlled Release (IF: 10.8), 2019, 316: 381-392.  

11.Xiaoyi Wang, Huan Wang, Kuan Jiang, Yanyu Zhang, Changyou Zhan, Man Ying, Mingfei Zhang, Linwei Lu, Ruifeng Wang, Songli Wang, Diane J. Burgess, Hao Wang, Weiyue Lu. Liposomes with Cyclic RGD Peptide Motif Triggers Acute Immune Response In Mice [J]. Journal of Controlled Release (IF: 10.8), 2019, 293: 201-214. 

12.Xiaoyi Wang, Weiyue Lu. Active Targeting Liposomes: Promising Approach for Tumor-Targeted Therapy [J]. Journal of Bioequivalence & Bioavailability, 2016, 8: 013-014.  

13.Xiaoyi Wang, Jianping Zhou, Wei Wang. Reconstituted High Density Lipoprotein-Based Nanoparticles: An Overview of Applications In Regenerative Medicine, Preparation, Evaluation and Future Trends [J]. Current Pharmaceutical Design (IF: 3.1), 2015, 21: 1529-1544.  

14.王晓艺, 王伟, 王程, 李运曼, 黄文龙, 周建平. HZ08新型仿生纳米粒的构建与性质研究[J]. 药学与临床研究, 2014, 22(4): 293-298.